In this study, vitamin E was employed as a positive control, supplementing vitamin E with ACR reduced movement disorders, reduced MDA, increased GSH content, and significantly reduced TNF-α, and caspase-3 levels in cortex tissue compared to the ACR receiving group. The gene discussed is TNF; the disease is movement disorder.